Roth MKM Maintains Buy on Aspen Aerogels, Lowers Price Target to $16
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Roth MKM analyst Chip Moore maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $22 to $16.
Roth MKM analyst Chip Moore maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $22 to $16.